2C-CP
Chemical compound
2C-CP | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
2C-cP is a lesser-known psychedelic compound of the 2C family, which was first synthesized by Alexander Shulgin. It is a structural analog of 2C-B and 2C-I, but with a cyclopropyl group replacing the halogen or alkyl group typically found in these compounds.
Chemical Structure
2C-cP is a phenethylamine derivative, characterized by a phenyl ring bound to an amino group through an ethyl chain. The phenyl ring is substituted with two methoxy groups at the 2 and 5 positions, and a cyclopropyl group at the 4 position. This unique substitution pattern is responsible for its distinct pharmacological properties.
Pharmacology
The pharmacological effects of 2C-cP are not well-documented, but it is believed to act as a partial agonist at the 5-HT2A receptor, similar to other compounds in the 2C series. This receptor is known to play a significant role in the modulation of mood, perception, and cognition, which are typically affected by psychedelic substances.
Effects
The effects of 2C-cP are largely anecdotal, as it has not been widely studied in humans. Users have reported experiencing altered states of consciousness, visual and auditory hallucinations, and changes in perception and mood. The intensity and duration of these effects can vary significantly depending on the dose and individual sensitivity.
Safety and Toxicity
Due to the lack of scientific research, the safety profile of 2C-cP is not well understood. As with other research chemicals, there is a potential risk of adverse effects, including psychological distress, tachycardia, and hypertension. It is advised to approach the use of such substances with caution and awareness of the potential risks involved.
Legal Status
The legal status of 2C-cP varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to other regulated 2C compounds. It is important for individuals to be aware of and comply with local laws regarding the possession and use of such substances.
Synthesis
The synthesis of 2C-cP involves the reaction of 2,5-dimethoxybenzaldehyde with cyclopropylmagnesium bromide, followed by reductive amination with ammonia or an amine source. This process requires advanced knowledge of organic chemistry and access to specialized laboratory equipment.
Related Compounds
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD